Quantitative MRI using STrategically Acquired Gradient Echo (STAGE): optimization for 1.5 T scanners and T1 relaxation map validation

An update on susceptibility-weighted imaging in brain gliomas

Susceptibility-weighted imaging (SWI) has become a standard component of most brain MRI protocols. While traditionally used for detecting and characterising brain hemorrhages typically associated with stroke or trauma, SWI has also shown promising results in glioma assessment. Numerous studies have highlighted SWI's role in differentiating gliomas from other brain lesions, such as primary central nervous system lymphomas or metastases. Additionally, SWI aids radiologists in non-invasively grading gliomas and predicting their phenotypic profiles. Various researchers have suggested incorporating SWI as an adjunct sequence for predicting treatment response and for post-treatment monitoring. A significant focus of these studies is on the detection of intratumoural susceptibility signals (ITSSs) in gliomas, which are indicative of microhemorrhages and vessels within the tumour. The quantity, distribution, and characteristics of these ITSSs can provide radiologists with more precise information for evaluating and characterising gliomas. Furthermore, the potential benefits and added value of performing SWI after the administration of gadolinium-based contrast agents (GBCAs) have been explored. This review offers a comprehensive, educational, and practical overview of the potential applications and future directions of SWI in the context of glioma assessment. CLINICAL RELEVANCE STATEMENT: SWI has proven effective in evaluating gliomas, especially through assessing intratumoural susceptibility signal changes, and is becoming a promising, easily integrated tool in MRI protocols for both pre- and post-treatment assessments. KEY POINTS: • Susceptibility-weighted imaging is the most sensitive sequence for detecting blood and calcium inside brain lesions. • This sequence, acquired with and without gadolinium, helps with glioma diagnosis, characterisation, and grading through the detection of intratumoural susceptibility signals. • There are ongoing challenges that must be faced to clarify the role of susceptibility-weighted imaging for glioma assessment.

A rapid multi-parametric quantitative MR imaging method to assess Parkinson's disease: a feasibility study

BACKGROUND

MULTIPLEX is a single-scan three-dimensional multi-parametric MRI technique that provides 1 mm isotropic T1-, T2*-, proton density- and susceptibility-weighted images and the corresponding quantitative maps. This study aimed to investigate its feasibility of clinical application in Parkinson's disease (PD).

METHODS

27 PD patients and 23 healthy control (HC) were recruited and underwent a MULTIPLEX scanning. All image reconstruction and processing were automatically performed with in-house C + + programs on the Automatic Differentiation using Expression Template platform. According to the HybraPD atlas consisting of 12 human brain subcortical nuclei, the region-of-interest (ROI) based analysis was conducted to extract quantitative parameters, then identify PD-related abnormalities from the T1, T2* and proton density maps and quantitative susceptibility mapping (QSM), by comparing patients and HCs.

RESULTS

The ROI-based analysis revealed significantly decreased mean T1 values in substantia nigra pars compacta and habenular nuclei, mean T2* value in subthalamic nucleus and increased mean QSM value in subthalamic nucleus in PD patients, compared to HCs (all p values < 0.05 after FDR correction). The receiver operating characteristic analysis showed all these four quantitative parameters significantly contributed to PD diagnosis (all p values < 0.01 after FDR correction). Furthermore, the two quantitative parameters in subthalamic nucleus showed hemicerebral differences in regard to the clinically dominant side among PD patients.

CONCLUSIONS

MULTIPLEX might be feasible for clinical application to assist in PD diagnosis and provide possible pathological information of PD patients' subcortical nucleus and dopaminergic midbrain regions.

Automatic brain extraction and brain tissues segmentation on multi-contrast animal MRI

For many neuroscience applications, brain extraction in MRI images is the first pre-processing step of a quantification pipeline. Once the brain is extracted, further post-processing calculations become faster, more specific and easier to implement and interpret. It is the case, for example, of functional MRI brain studies, or relaxation time mappings and brain tissues classifications to characterise brain pathologies. Existing brain extraction tools are mostly adapted to work on the human anatomy, this gives poor results when applied to animal brain images. We have developed an atlas-based Veterinary Images Brain Extraction (VIBE) algorithm that encompasses a pre-processing step to adapt the atlas to the patient's image, and a subsequent registration step. We show that the brain extraction is achieved with excellent results in terms of Dice and Jaccard metrics. The algorithm is automatic, with no need to adapt the parameters in a broad range of situations: we successfully tested multiple MRI contrasts (T1-weighted, T2-weighted, T2-weighted FLAIR), all the acquisition planes (sagittal, dorsal, transverse), different animal species (dogs and cats) and canine cranial conformations (brachycephalic, mesocephalic, dolichocephalic). VIBE can be successfully extended to other animal species, provided that an atlas for that specific species exists. We show also how brain extraction, as a preliminary step, can help to segment brain tissues with a K-Means clustering algorithm.